AstraZeneca said on Tuesday it will buy Canadian drug developer Fusion Pharmaceuticals for $2 billion in cash as the drugmaker bets on next-generation cancer treatments. The deal gives AstraZeneca a foothold in the...
Eris Lifesciences acquires Biocon Biologics domestic branded formulation business for Rs 1,242 crore
Eris Lifesciences on Thursday announced the acquisition of Biocon Biologics’ India branded formulation business for Rs. 1,242 crore. Eris has also signed a 10-year supply agreement with Biocon Biologics as a part of...
Suven Pharma, Cohance Lifesciences to merge to bolster CDMO business
Suven Pharmaceuticals Ltd and Cohance Lifesciences Ltd signed a definitive agreement to merge their businesses, which will further strengthen the former’s position in the contract development and manufacturing...
KKR considers selling stake in India’s $3 billion JB Pharma
KKR & Co. is exploring options including selling its controlling stake in India’s JB Chemicals & Pharmaceuticals Ltd. amid interest from potential buyers, according to people familiar with the matter. The US...
Nirma issues bonds to fund Glenmark Life Sciences acquisition: Bankers
India’s Nirma has accepted bids aggregating to 35 billion rupees ($422 million) for a three-part shorter-tenor bonds to fund its acquisition of a 75% stake in Glenmark Pharma’s life sciences unit, three...
Sun Pharma to acquire 16.33 pc stake in Surgimatix for USD 3.05 mn
Sun Pharmaceutical Industries Ltd said it will acquire a 16.33 per cent stake in Surgimatix, Inc, a US-based firm for USD 3.05 million (over Rs 25 crore). Surgimatix is engaged in the business of developing a...
GSK completes acquisition of Aiolos Bio for up to $1.4 bln
GSK said on Thursday it had completed the acquisition of Aiolos Bio, a clinical-stage biopharmaceutical company focused on respiratory and inflammatory conditions. GSK will pay $1 billion upfront and up to $400 million...
Eris acquires 51 pc stake in Swiss Parenterals for Rs 637.5 cr
Eris Lifesciences on Tuesday said it has acquired a 51 per cent stake in Swiss Parenterals for Rs 637.5 crore. Ahmedabad-based Swiss Parenterals is a leading player in the sterile injectables business in over 80...
ChrysCapital close to acquiring 5-6% in pharma co La Renon Healthcare
Homegrown private equity fund ChrysCapital is close to acquiring 5-6% stake in pharmaceutical company La Renon Healthcare via secondary sale of shares at an estimated valuation of ₹6,500 crore, or $800 million, multiple...
Thyrocare to buy home ECG service provider Think Health
Pharmeasy-backed diagnostic provider Thyrocare, said it will be acquiring 100% stake in Chennai-based Think Health Diagnostics to enter into providing electrocardiogram (ECG) services at home. The financial details of...
Novartis to acquire cancer-focused MorphoSys for $2.9 billion
Drugmaker Novartis AG said it will acquire MorphoSys AG, a developer of cancer treatments, for 2.7 billion euros ($2.9 billion), adding a promising rare bone-marrow cancer treatment candidate to its portfolio. Reuters...
Sino Biopharmaceutical to divest 67% stake in unit CP Qingdao for $253 mln
Hong Kong-listed Sino Biopharmaceutical will sell a 67% stake in unit CP Pharmaceutical (Qingdao) for 1.82 billion yuan ($253.28 million) to entities controlled by state-owned Guoxin Group, the company said late on...
